Drug therapy for alcohol dependence

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

The neural basis of drug craving: An incentive-sensitization theory of addiction

Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · see citing works

Actual causes of death in the United States

McGinnis, J. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180077038 · Cited by 5,480 · see citing works

Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse: Results From the Epidemiologic Catchment Area (ECA) Study

Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · see citing works

A psychomotor stimulant theory of addiction.

Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747 · see citing works

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538 · see citing works

Lifetime Co-occurrence of DSM-III-R Alcohol Abuse and Dependence With Other Psychiatric Disorders in the National Comorbidity Survey

Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085 · see citing works

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828 · see citing works

Naltrexone and Coping Skills Therapy for Alcohol Dependence

O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,466 · see citing works

The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment.

Helzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,092 · see citing works

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area

Gessa, G. L., Francesco Muntoni, A., Collu, M., Vargiu, L., & Mereu, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90381-6 · Cited by 770 · see citing works

The Obsessive Compulsive Drinking Scale: A Self‐Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking Behavior

Anton, R. F., Moak, D. H., & Latham, P. K. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 679 · see citing works

Actual causes of death in the United States

McGinnis, J. M. (1993) · JAMA · doi:10.1001/jama.270.18.2207 · Cited by 579 · see citing works

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541 · see citing works

Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

Suzdak, P. D., Schwartz, R. D., Skolnick, P., & Paul, S. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4071 · Cited by 539 · see citing works

The Obsessive Compulsive Drinking Scale

Anton, R. F. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030047008 · Cited by 507 · see citing works

Relapse Prevention by Acamprosate

Saß, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 477 · see citing works

Naltrexone and Alcohol Dependence

Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411 · see citing works

The glutamatergic basis of human alcoholism

Tsai, G. E., Gastfriend, D. R., & COYLE, J. T. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.332 · Cited by 385 · see citing works

Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies

LeMarquand, D. G., Pihl, R. O., & Benkelfat, C. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91215-7 · Cited by 374 · see citing works

Disulfiram Treatment of Alcoholism

Chick, J., Gough, K. A., Falkowski, W., Kershaw, P. W., Hore, B. D., Mehta, B. M., Ritson, B., Ropner, R., & Torley, D. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.1.84 · Cited by 369 · see citing works

Fluoxetine in Depressed Alcoholics

Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 356 · see citing works

5-HT and alcohol abuse

Sellers, E. M., Higgins, G. A., & Sobell, M. B. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90026-3 · Cited by 325 · see citing works

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

Whitworth, A. B., OBERBAUER, H., Fleischhacker, W. W., Lesch, O., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 319 · see citing works

Effect of naltrexone on alcohol “high” in alcoholics

(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308 · see citing works

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

Froehlich, J. C., Hurley, J. H., Lumeng, L., & Li, T. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90174-g · Cited by 296 · see citing works

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

Kranzler, H. R., Burleson, J., Körner, P., Boca, F. K. D., Bohn, M. J., Brown, J., & LIEBOWITZ, N. R. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.391 · Cited by 289 · see citing works

Acamprosate in alcohol dependence: how does it work?

Littleton, J. M. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.90911793.x · Cited by 278 · see citing works

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00174-4 · Cited by 277 · see citing works

Neurobiology of alcohol abuse

Samson, H. H., & Harris, R. A. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90065-e · Cited by 268 · see citing works

A Double-blind, Placebo-Controlled Trial of Desipramine for Primary Alcohol Dependence Stratified on the Presence or Absence of Major Depression

Mason, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03530340025025 · Cited by 257 · see citing works

Naltrexone-induced alterations in human ethanol intoxication

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254 · see citing works

Buspirone Treatment of Anxious Alcoholics: A Placebo-Controlled Trial

Kranzler, H. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090052008 · Cited by 248 · see citing works

A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence

Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F., Goldberg, G., Welch, B., & Mantero-atienza, E. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 248 · see citing works

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats

Benjamin, D., Grant, E. R., & Pohorecky, L. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90309-b · Cited by 242 · see citing works

Gamma‐Hydroxybutyric Acid in the Treatment of Alcohol Dependence: A Double‐Blind Study

Gallimberti, L., Ferri, M., Ferrara, S. D., Fadda, F., & Gessa, G. L. (1992) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb00658.x · Cited by 240 · see citing works

The serotonin uptake inhibitor citalopram attenuates ethanol intake

Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236 · see citing works

The Safety Profile of Naltrexone in the Treatment of Alcoholism

Croop, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240090013 · Cited by 220 · see citing works

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations

Hubbell, C. L., Czirr, S. A., Hunter, G. A., Beaman, C. M., LeCann, N. C., & Reid, L. D. (1986) · Alcohol · doi:10.1016/0741-8329(86)90070-4 · Cited by 217 · see citing works

Imipramine Treatment of Alcoholics With Primary Depression

McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212 · see citing works

The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects

Finney, J. W., HAHN, A. C., & Moos, R. H. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911217733.x · Cited by 188 · see citing works

ACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS

Lhuintre, J. P., MOORE, N., TRAN, G., Stéru, L., LANGRENON, S., DAOUST, S., PAROT, P., Ladure, P., LIBERT, C., BOISMARE, F., et al. (1990) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045057 · Cited by 187 · see citing works

Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence

Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., & Sobell, M. B. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00054.x · Cited by 184 · see citing works

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

Malcolm, R. J., Ballenger, J. C., Sturgis, E. T., & Anton, R. F. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.5.617 · Cited by 180 · see citing works

Alcohol Withdrawal and Noradrenergic Function

Linnoila, M., Mefford, I. N., Nutt, D., & ADINOFF, B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-875 · Cited by 180 · see citing works

Acamprosate in alcohol dependence: how does it work?

Littleton, J. M. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 177 · see citing works

Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele

Lawford, B. R., Young, R. M., Rowell, J., Qualichefski, J., Fletcher, B. H., Syndulko, K., Ritchie, T. L., & Noble, E. P. (1995) · Nature Medicine · doi:10.1038/nm0495-337 · Cited by 176 · see citing works

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors

Zeise, M. L., Kasparov, S., Capogna, M., & Zieglgänsberger, W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90682-8 · Cited by 175 · see citing works

Lithium Treatment of Depressed and Nondepressed Alcoholics

Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164 · see citing works

Critical review of liability for benzodiazepine abuse among alcoholics

Ciraulo, D. A., Sands, B. F., & Shader, R. I. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1501 · Cited by 162 · see citing works

The efficacy of disulfiram: a review of outcome studies

HUGHES, J. C., & COOK, C. C. H. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03370.x · Cited by 162 · see citing works

A Placebo‐Controlled Trial of Buspirone in Anxious Inpatient Alcoholics

Malcolm, R. J., Anton, R. F., Randall, C. L., Johnston, A. L., Brady, K. T., & Thevos, A. K. (1992) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb00691.x · Cited by 157 · see citing works

Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms.

Nie, Z., Madamba, S. G., & Siggins, G. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23989-1 · Cited by 153 · see citing works

Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching.

Jaffe, A. J., Rounsaville, B. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & O'Malley, S. S. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.5.1044 · Cited by 149 · see citing works

Ethanol and the NMDA receptor

Hoffman, P. L., Rabe, C. S., Grant, K. A., Valverius, P., Hudspith, M. J., & Tabakoff, B. (1990) · Alcohol · doi:10.1016/0741-8329(90)90010-a · Cited by 144 · see citing works

Buspirone in the Treatment of Alcoholic Patients

Bruno, F. (2010) · Psychopathology · doi:10.1159/000284626 · Cited by 139 · see citing works

Acamprosate treatment in a long-term community-based alcohol rehabilitation programme

Poldrugo, F. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02873.x · Cited by 133 · see citing works

The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism

Morse, R. M. (1992) · JAMA · doi:10.1001/jama.268.8.1012 · Cited by 133 · see citing works

Neuropharmacology of Cocaine and Ethanol Dependence

Koob, G. F., & Weiss, F. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_11 · Cited by 124 · see citing works

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.

Mueller, T. I., Stout, R. L., Rudden, S., Brown, R. A., Gordon, A. A., Solomon, D. A., & Recupero, P. R. (1997) · PubMed · Cited by 117 · see citing works

A Double‐Blind, Placebo‐Controlled Pilot Study of Carbamazepine for the Treatment of Alcohol Dependence

Mueller, T. I., Stout, R. L., Rudden, S., Brown, R. A., Gordon, A. A., Solomon, D. A., & Recupero, P. R. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03733.x · Cited by 114 · see citing works

Naltrexone Increases the Latency to Drink Alcohol in Social Drinkers

Davidson, D., Swift, R. M., & Fitz, E. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01679.x · Cited by 111 · see citing works

Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching.

Jaffé, A., Rounsaville, B. J., Chang, G., et al. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.5.1044 · Cited by 108 · see citing works

Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats

Knapp, D. J., & Pohorecky, L. A. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90237-a · Cited by 106 · see citing works

The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects

Finney, J. W., HAHN, A. C., & Moos, R. H. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb03801.x · Cited by 105 · see citing works

Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine.

George, S. R., Fan, T., Ng, G., Jung, S., O’Dowd, B. F., & Naranjo, C. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09574-6 · Cited by 103 · see citing works

Acamprosate and Prevention of Relapse in Alcoholics

Geerlings, P. J., Ansoms, C., & van den Brink, W. (2009) · European Addiction Research · doi:10.1159/000259166 · Cited by 101 · see citing works

Cue elicited urge to drink and salivation in alcoholics: Relationship to individual differences

Rohsenow, D. J., Monti, P. M., Abrams, D. B., Rubonis, A. V., NIAURA, R. S., Sirota, A. D., & Colby, S. M. (1992) · Advances in Behaviour Research and Therapy · doi:10.1016/0146-6402(92)90008-c · Cited by 100 · see citing works

Tiapride in the Prevention of Relapse in Recently Detoxified Alcoholics

Shaw, G. K., Waller, S., Majumdar, S. K., Alberts, J. L., Latham, C. J., & Dunn, G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.4.515 · Cited by 99 · see citing works

Pharmacotherapies for Alcohol Problems: A Review of Research with Focus on Developments since 1991

Litten, R. Z., Allen, J., & Fertig, J. B. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05264.x · Cited by 97 · see citing works

Naltrexone treatment of comorbid alcohol and cocaine use disorders

Hersh, D., Kirk, J. R. V., & Kranzler, H. R. (1998) · Psychopharmacology · doi:10.1007/s002130050688 · Cited by 93 · see citing works

Buspirone attenuates volitional alcohol intake in the chronically drinking monkey

Collins, D. M., & Myers, R. D. (1987) · Alcohol · doi:10.1016/0741-8329(87)90060-7 · Cited by 87 · see citing works

Ritanserin in the treatment of alcohol dependence - a multi-center clinical trial

Johnson, B. A., Jasinski, D. R., Galloway, G. P., Kranzler, H. R., Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati, H. M., Rawson, R. A., et al. (1996) · Psychopharmacology · doi:10.1007/s002130050126 · Cited by 87 · see citing works

Current concepts of ethanol dependence

Littleton, J. M., & Little, H. J. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03736.x · Cited by 82 · see citing works

Tiapride

Peters, D. H., & Faulds, D. M. (1994) · Drugs · doi:10.2165/00003495-199447060-00009 · Cited by 81 · see citing works

Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats

Daoust, M., Legrand, E., Gewiss, M., Heidbreder, C. A., DeWitte, P., Tran, G., & Durbin, P. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90210-7 · Cited by 78 · see citing works

Fluoxetine attenuates alcohol intake and desire to drink

Naranjo, C. A., Poulos, C. X., Bremner, K. E., & Lanctôt, K. L. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00004 · Cited by 77 · see citing works

Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

Kranzler, H. R., & Anton, R. F. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.6.1116 · Cited by 75 · see citing works

Buspirone in the Treatment of Alcohol Dependence: A Placebo‐Controlled Trial

Malec, E., Malec, T., Gagné, M., & Dongier, M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01644.x · Cited by 70 · see citing works

Lithium Carbonate and Ethanol Induced "Highs" in Normal Subjects

Judd, L. L. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770160097008 · Cited by 67 · see citing works

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

Mason, B. J. (1996) · JAMA · doi:10.1001/jama.275.10.761 · Cited by 62 · see citing works

Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

Kranzler, H. R., & Anton, R. F. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.6.1116 · Cited by 62 · see citing works

Broadening the Base of Treatment for Alcohol Problems:Report of a Study by a Committee of the Institute of Medicine Division of Mental Health and Behavioral Medicine

Schuckit, M. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1589-a · Cited by 61 · see citing works

More on Idiosyncratic Reaction to Naltrexone

Malcolm, R. J., Gabel, T. L., & MORTON, A. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.1.124-b · Cited by 60 · see citing works

Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization

Broadbent, J., Grahame, N. J., & Cunningham, C. L. (1995) · Psychopharmacology · doi:10.1007/bf02245821 · Cited by 55 · see citing works

Long-acting injectable bromocriptine does not reduce relapse in alcoholics

Naranjo, C. A., Dongier, M., & Bremner, K. E. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02976.x · Cited by 53 · see citing works

A Risk-Benefit Assessment of Naltrexone in the Treatment of Alcohol Dependence

Berg, B. J., Pettinati, H. M., & Volpicelli, J. R. (1996) · Drug Safety · doi:10.2165/00002018-199615040-00005 · Cited by 48 · see citing works

Conference Summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment

Chick, J., & Erickson, C. K. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01658.x · Cited by 42 · see citing works

Interactions of serotonin with ethanol: clinical and animal studies.

Linnoila, M., Eckardt, M., Durcan, M. J., Lister, R. G., & Martin, P. (1987) · PubMed · Cited by 42 · see citing works

Calcium Carbimide in Alcoholism Treatment. Part 1: a placebo‐controlled, double‐blind clinical trial of short‐term efficacy⋆

Peachey, J. E., Annis, H. M., BORNSTEIN, E. R., Sykora, K., MAGLANA, S. M., & Shamai, S. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00760.x · Cited by 38 · see citing works

Lithium treatment of depressed and nondepressed alcoholics

Dorus, W. (1989) · JAMA · doi:10.1001/jama.262.12.1646 · Cited by 38 · see citing works

Evaluation of lithium treatment in alcoholism.

Lejoyeux, M., & Adès, J. (1993) · PubMed · Cited by 35 · see citing works

Alcohol sensitivity and dependence

Schuckit, M. A. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_34 · Cited by 34 · see citing works

Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications

Naranjo, C. A., & Bremner, K. E. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_21 · Cited by 33 · see citing works

Dosing Issues in the Pharmacotherapy of Alcoholism

Mason, B. J. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01184.x · Cited by 33 · see citing works

[Acamprosate. From pharmacology to therapeutics].

Nalpas, B., Dabadie, H., Parot, P., & Paccalin, J. (1990) · PubMed · Cited by 32 · see citing works

The role of the mesoaccumbens dopamine system in ethanol reinforcement: studies using the techniques of microinjection and voltammetry.

Hh, S., & Hodge, C. W. (1993) · PubMed · Cited by 31 · see citing works

Acamprosate as an aid in the treatment of alcoholism.

Chick, J. (1995) · PubMed · Cited by 21 · see citing works

Changes in Transaminases Over the Course of a 12‐Week, Double‐Blind Nalmefene Trial in a 38‐Year‐Old Female Subject

Salvato, F. R., & Mason, B. J. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00102.x · Cited by 11 · see citing works

Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary data.

Soyka, M., & Sass, H. (1994) · PubMed · Cited by 10 · see citing works

Pharmacological Treatment

Gorelick, D. A. (1993) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1742-3_22 · Cited by 8 · see citing works

Alcohol and public health

Room, R., Babor, T., & Rehm, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17870-2 · Cited by 1,625 · see citing works

Gambling and the Health of the Public: Adopting a Public Health Perspective

Korn, D. A., & Shaffer, H. J. (1999) · Journal of Gambling Studies · doi:10.1023/a:1023005115932 · Cited by 536 · see citing works

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

Alvarez, C. B., Magro, A., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504 · see citing works

BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY

Addolorato, G. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.504 · Cited by 479 · see citing works

Drug Addiction

Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477 · see citing works

The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol‐Dependent Individuals: Results of a Meta‐Analysis

Mann, K. F., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 363 · see citing works

Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis

Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347 · see citing works

Toxic Leukoencephalopathy

Filley, C. M., & Kleinschmidt‐DeMasters, B. K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450606 · Cited by 340 · see citing works

Why Physicians Are Unprepared to Treat Patients Who Have Alcohol- and Drug-related Disorders

Miller, N. S., Sheppard, L. M., Colenda, C. C., & Magen, J. G. (2001) · Academic Medicine · doi:10.1097/00001888-200105000-00007 · Cited by 323 · see citing works

Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?

Kuhn, J., Lenartz, D., Huff, W., Lee, S. J., Koulousakis, A., Klosterkoetter, J., & Sturm, V. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.113092 · Cited by 284 · see citing works

Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings

Johnson, B. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 265 · see citing works

Acamprosate Efficacy in Alcohol‐Dependent Patients: Summary of Results from Three Pivotal Trials

Kranzler, H. R., & Gage, A. T. (2008) · American Journal on Addictions · doi:10.1080/10550490701756120 · Cited by 212 · see citing works

Alcoholism and suicidal behavior: a clinical overview

Sher, L. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00643.x · Cited by 210 · see citing works

Ability of Baclofen in Reducing Alcohol Craving and Intake: II???Preliminary Clinical Evidence

Addolorato, G., Caputo, F., Capristo, E., G., C., Gessa, G. L., & Gasbarrini, A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04555.x · Cited by 203 · see citing works

Pharmacotherapy of Alcohol Dependence

Mann, K. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418080-00002 · Cited by 198 · see citing works

Research to practice

Parks, C. L., Wallack, S. S., Lee, S., McCarty, D. W., & Swift, R. M. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00319-7 · Cited by 183 · see citing works

The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use

Weiss, R. D., Griffin, M. L., Mazurick, C., Berkman, B., Gastfriend, D. R., Frank, A., Barber, J. P., Blaine, J., Salloum, I., & Moras, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1320 · Cited by 171 · see citing works

NALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · see citing works

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology

Lingford-Hughes, A. R., Welch, S., & Nutt, D. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800321 · Cited by 168 · see citing works

Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease

Leggio, L., & Lee, M. R. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.10.004 · Cited by 168 · see citing works

A Pilot Trial of the Alpha‐1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence

Simpson, T. L., Saxon, A. J., Meredith, C. W., Malte, C. A., McBride, B., Ferguson, L. C., Gross, C., Hart, K. L., & Raskind, M. A. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00807.x · Cited by 159 · see citing works

Medication treatment of different types of alcoholism

Johnson, B. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.08101500 · Cited by 151 · see citing works

Antidepressant treatment of co-occurring depression and alcohol dependence

Pettinati, H. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.016 · Cited by 141 · see citing works

Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence.

Tomkins, D. M., & Sellers, E. M. (2001) · Europe PMC (PubMed Central) · Cited by 129 · see citing works

Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders

Barrick, C., & Connors, G. J. (2002) · Drugs & Aging · doi:10.2165/00002512-200219080-00004 · Cited by 126 · see citing works

New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications

Leggio, L., Kenna, G. A., & Swift, R. M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.021 · Cited by 120 · see citing works

Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients

Leggio, L., Garbutt, J. C., & Addolorato, G. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966614 · Cited by 116 · see citing works

Evidence-based practices for substance use disorders

McGovern, M. P., & Carroll, K. M. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00073-x · Cited by 112 · see citing works

A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone

Mason, B. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00368-8 · Cited by 110 · see citing works

Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study

Wiesbeck, G. A. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.329 · Cited by 110 · see citing works

Management of Alcohol Dependence in Patients with Liver Disease

Addolorato, G., Mirijello, A., Leggio, L., Ferrulli, A., & Landolfi, R. (2013) · CNS Drugs · doi:10.1007/s40263-013-0043-4 · Cited by 110 · see citing works

Quality of life, depression and anxiety in alcohol dependence

Saatçioğlu, Ö., Eslek, A. Y., & Çakmak, D. (2007) · Drug and Alcohol Review · doi:10.1080/09595230701711140 · Cited by 108 · see citing works

An Extract of the Chinese Herbal Root Kudzu Reduces Alcohol Drinking by Heavy Drinkers in a Naturalistic Setting

Lukas, S. E., Penetar, D. M., Berko, J., Vicens, L., Palmer, C., Mallya, G. K., Macklin, E. A., & Lee, D. Y. W. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000163499.64347.92 · Cited by 97 · see citing works

The Role of Craving in Alcohol Use, Dependence, and Treatment

Flannery, B., Roberts, A. J., Cooney, N. L., Swift, R. M., Anton, R. F., & Rohsenow, D. J. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02213.x · Cited by 96 · see citing works

A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence

Roozen, H. G., de Waart, R., van der Windt, D., van den Brink, W., de Jong, C. A. J., & Kerkhof, A. J. F. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.001 · Cited by 96 · see citing works

Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study

Mann, K. F., Kiefer, F., Smolka, M. N., Gann, H., Wellek, S., & Heinz, A. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00884.x · Cited by 94 · see citing works

Pharmacotherapy for Alcohol Use Disorder

Swift, R. M., & Aston, E. R. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000079 · Cited by 92 · see citing works

The BRENDA Model: Integrating Psychosocial Treatment and Pharmacotherapy for the Treatment of Alcohol Use Disorders

Starosta, A., Leeman, R. F., & Volpicelli, J. R. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200603000-00003 · Cited by 93 · see citing works

Role of the Serotonergic System in Alcohol Dependence

Sari, Y., Johnson, V. R., & Weedman, J. M. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00010-7 · Cited by 91 · see citing works

Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients

Addolorato, G., & Leggio, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516440 · Cited by 91 · see citing works

Improvement in Quality of Life After Treatment for Alcohol Dependence With Acamprosate and Psychosocial Support

Morgan, M. Y., Landron, F., Lehert, P., & for the New European Alcoholism Treatment Study Group (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000108652.73143.4b · Cited by 89 · see citing works

Tobacco-associated lesions of the oral cavity: Part I. Nonmalignant lesions.

Mirbod, S. M., & Ahing, S. I. (2000) · PubMed · Cited by 89 · see citing works

Review of Treatment Recommendations for Persons With a Co-occurring Affective or Anxiety and Substance Use Disorder

Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.8.913 · Cited by 87 · see citing works

Effect of Baclofen on Alcohol and Sucrose Self-Administration in Rats

Anstrom, K. K., Cromwell, H. C., Markowski, T., & Woodward, D. J. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb04414.x · Cited by 86 · see citing works

Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi‐centre, randomized, single‐blind comparison trial

Martinotti, G., Nicola, M. D., Frustaci, A., Romanelli, R., Tedeschi, D., Guglielmo, R., Guerriero, L., Bruschi, A., de Filippis, R., Pozzi, G., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02792.x · Cited by 80 · see citing works

A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long‐Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence

Johnson, B. A., Ait‐Daoud, N., Aubin, H., van den Brink, W., Guzzetta, R. V., Loewy, J. W., Silverman, B. L., & Ehrich, E. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139823.30096.52 · Cited by 82 · see citing works

The European Acamprosate Trials: Conclusions for Research and Therapy

Lesch, O., Riegler, A., Gutiérrez, K., Hertling, I., Ramskogler, K., Semler, B., Zoghlami, A., Benda, N., & Walter, H. (2001) · Journal of Biomedical Science · doi:10.1007/bf02255976 · Cited by 81 · see citing works

Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice

Middaugh, L. D., & Bandy, A. E. (2000) · Psychopharmacology · doi:10.1007/s002130000479 · Cited by 79 · see citing works

Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats

Adams, C. L., Cowen, M. S., Short, J. L., & Lawrence, A. J. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007845 · Cited by 78 · see citing works

Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.

Dundon, W. D., Lynch, K., Pettinati, H., & Lipkin, C. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000130974.50563.04 · Cited by 75 · see citing works

Client and counselor attitudes toward the use of medications for treatment of opioid dependence

Rieckmann, T. R., Daley, M. C., Fuller, B. E., Thomas, C. P., & McCarty, D. W. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.09.002 · Cited by 75 · see citing works

Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology

Erve, J. C. L. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.923 · Cited by 74 · see citing works

Baclofen: a new drug for the treatment of alcohol dependence

Addolorato, G., Leggio, L., Agabio, R., Colombo, G., & Gasbarrini, A. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01065.x · Cited by 72 · see citing works

The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview

Martinotti, G., Lupi, M., Sarchione, F., Santacroce, R., Salone, A., Berardis, D. D., Serroni, N., Cavuto, M., Signorelli, M. S., Aguglia, E., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990425 · Cited by 72 · see citing works

Eosinophils in the Lung – Modulating Apoptosis and Efferocytosis in Airway Inflammation

Felton, J. M., Lucas, C. D., Rossi, A. G., & Dransfield, I. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00302 · Cited by 73 · see citing works

Predictors of Compliance with Naltrexone Among Alcoholics

Rohsenow, D. J., Colby, S. M., Monti, P. M., Swift, R. M., Martin, R. A., Mueller, T. I., Gordon, A. A., & Eaton, C. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04573.x · Cited by 69 · see citing works

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.

Pelc, I., Ansoms, C., Lehert, P., Fischer, F., Fuchs, W.-J., Landron, F., Preto, A. J. P., & Morgan, M. Y. (2002) · PubMed · doi:10.1097/01.alc.0000029584.62149.22 · Cited by 66 · see citing works

Naltrexone: A review of existing sustained drug delivery systems and emerging nano-based systems

Goonoo, N., Bhaw‐Luximon, A., Ujoodha, R., Jhugroo, A., Hulse, G. K., & Jhurry, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.046 · Cited by 65 · see citing works

Current Pharmacotherapies of Alcoholism: A U.S. Perspective

Anton, R. F., & Swift, R. M. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00496.x · Cited by 65 · see citing works

DOES PSYCHOSOCIAL TREATMENT ENHANCE THE EFFICACY OF ACAMPROSATE IN PATIENTS WITH ALCOHOL PROBLEMS?

de Wildt, W. A. J. M. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.4.375 · Cited by 64 · see citing works

Medications and alcohol craving.

Swift, R. M. (1999) · PubMed Central · Cited by 59 · see citing works

A Meta-Analysis of Transcranial Direct Current Stimulation on Substance and Food Craving: What Effect Do Modulators Have?

Chen, J., Qin, J., He, Q., & Zou, Z. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00598 · Cited by 58 · see citing works

The European NEAT Program: An Integrated Approach Using Acamprosate and Psychosocial Support for the Prevention of Relapse in Alcohol‐Dependent Patients With a Statistical Modeling of Therapy Success Prediction

Pelc, I., Ansoms, C., Lehert, P., Fischer, F., Fuchs, W.-J., Landron, F., Preto, A. J. P., & Morgan, M. Y. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02452.x · Cited by 55 · see citing works

Overview of harm reduction treatments for alcohol problems

Witkiewitz, K. A., & Marlatt, G. A. (2006) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.03.005 · Cited by 55 · see citing works

Influence of alcohol consumption on IBS and dyspepsia

Halder, S. L. S., Locke, G. R., Schleck, C. D., Zinsmeister, A. R., & Talley, N. J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00815.x · Cited by 50 · see citing works

Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics

Martinotti, G., Nicola, M. D., Tedeschi, D., Callea, A., Giannantonio, M. D., & Janiri, L. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.03.023 · Cited by 51 · see citing works

Effect of prefrontal tDCS on resting brain fMRI graph measures in Alcohol Use Disorders: A randomized, double-blind, sham-controlled study.

Holla, B., Biswal, J., Ramesh, V., Shivakumar, V., Bharath, R. D., Benegal, V., Venkatasubramanian, G., Chand, P., & Murthy, P. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109950 · Cited by 51 · see citing works

Pharmacotherapy for Alcohol Dependence: Anticraving Medications for Relapse Prevention

Jung, Y., & Namkoong, K. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.2.167 · Cited by 49 · see citing works

Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs

Saxon, A. J., & McCarty, D. W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.014 · Cited by 49 · see citing works

Topiramate for Alcohol Dependence

Olmsted, C. L., & Kockler, D. R. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l157 · Cited by 46 · see citing works

Acamprosate in the treatment of alcohol dependence

Mason, B. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2103 · Cited by 46 · see citing works

Effects of Beverages on Alcohol Metabolism: Potential Health Benefits and Harmful Impacts

Wang, F., Zhang, Y., Zhou, Y., Li, Y., Zhou, T., Zheng, J., Zhang, J., Li, S., Xu, D.-P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030354 · Cited by 45 · see citing works

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence

Mason, B. J., & Heyser, C. J. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903512943 · Cited by 43 · see citing works

Anti‐dipsotropic isoflavones: The potential therapeutic agents for alcohol dependence

Keung, W. M. (2003) · Medicinal Research Reviews · doi:10.1002/med.10049 · Cited by 42 · see citing works

Emerging approaches to managing alcohol dependence

Swift, R. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060644 · Cited by 41 · see citing works

ALCOHOL WITHDRAWAL

Chang, P. H., & Steinberg, M. B. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70372-2 · Cited by 40 · see citing works

Is Baclofen a Revolutionary Medication in Alcohol Addiction Management? Review and Recent Updates

Gorsane, M.-A., Kébir, O., Hache, G., Blecha, L., Aubin, H., Reynaud, M., & Benyamina, A. (2012) · Substance Abuse · doi:10.1080/08897077.2012.663326 · Cited by 38 · see citing works

Ethanol Reinforcement in Nondeprived Mice: Effects of Abstinence and Naltrexone

Middaugh, L. D., Lee, A. M., & Bandy, A. E. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200008000-00006 · Cited by 39 · see citing works

Suicide attempts and externalizing psychopathology in a nationally representative sample

Hills, A., Cox, B. J., McWilliams, L. A., & Sareen, J. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.01.004 · Cited by 39 · see citing works

Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles

Yin, W., Akala, E. O., & Taylor, R. E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00297-1 · Cited by 39 · see citing works

SHORT-TERM METHADONE ADMINISTRATION REDUCES ALCOHOL CONSUMPTION IN NON-ALCOHOLIC HEROIN ADDICTS

Caputo, F. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.2.164 · Cited by 39 · see citing works

Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease

Leggio, L., Kenna, G. A., Ferrulli, A., Zywiak, W. H., Caputo, F., Swift, R. M., & Addolorato, G. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1244 · Cited by 37 · see citing works

Acamprosate

Scott, L. J., Figgitt, D. P., Keam, S. J., & Waugh, J. (2005) · CNS Drugs · doi:10.2165/00023210-200519050-00006 · Cited by 37 · see citing works

Acupuncture for alcohol dependence: a systematic review.

Cho, S.-H., & Whang, W. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00959.x · Cited by 42 · see citing works

Substance abuse in adolescents: a complex conundrum for the clinician.

Greydanus, D., & Patel, D. R. (2003) · The Pediatric clinics of North America · doi:10.1016/s0031-3955(03)00079-8 · Cited by 37 · see citing works

Role of dopamine D3 receptors in the addictive properties of ethanol

Heidbreder, C. A., Andreoli, M., Marcon, C., Thanos, P. K., Ashby, C. R., & Gardner, E. L. (2004) · Drugs of today · doi:10.1358/dot.2004.40.4.820081 · Cited by 36 · see citing works

The History and Practice of College Health

Turner, H. S., & Hurley, J. L. (2015) · UKnowledge (University of Kentucky) · Cited by 34 · see citing works

Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review

Lohoff, F. W. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0079 · Cited by 33 · see citing works

Organizational Predictors of Pharmacological Innovation Adoption: The Case of Disulfiram

Knudsen, H. K., Roman, P. M., Ducharme, L. J., & Johnson, J. A. (2005) · Journal of Drug Issues · doi:10.1177/002204260503500308 · Cited by 33 · see citing works

Deep brain stimulation in addiction due to psychoactive substance use

Kuhn, J., Bührle, C., Lenartz, D., & Sturm, V. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53497-2.00021-8 · Cited by 32 · see citing works

A Pilot Study of Oxcarbazepine Versus Acamprosate in Alcohol‐Dependent Patients

Croissant, B., Diehl, A., Klein, O., Zambrano, S., Nakovics, H., Heinz, A., & Mann, K. F. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00082.x · Cited by 32 · see citing works

The Pharmacotherapy of Alcohol Dependence: A State of the Art Review

Sousa, A. D. (2010) · Mens Sana monographs · doi:10.4103/0973-1229.58820 · Cited by 31 · see citing works

Altered motor cortex excitability to magnetic stimulation in alcohol withdrawal syndrome.

Nardone, R., Bergmann, J., Kronbichler, M., Caleri, F., Lochner, P., Tezzon, F., Ladurner, G., & Golaszewski, S. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01131.x · Cited by 31 · see citing works

An approach to the patient with substance use and abuse.

Maldonado, J. (2010) · The Medical clinics of North America · doi:10.1016/j.mcna.2010.08.010 · Cited by 31 · see citing works

Non-invasive brain stimulation in the functional evaluation of alcohol effects and in the treatment of alcohol craving: a review.

Nardone, R., Bergmann, J., Christova, M., Lochner, P., Tezzon, F., Golaszewski, S., Trinka, E., & Brigo, F. (2012) · Neurosciences research · doi:10.1016/j.neures.2012.08.003 · Cited by 29 · see citing works

Naltrexone (50 mg) Plus Psychotherapy in Alcohol-Dependent Patients: A Meta-Analysis of Randomized Controlled Trials

Jarosz, J., Miernik, K., Wąchal, M., Walczak, J., & Krumpl, G. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.796961 · Cited by 30 · see citing works

Alcoholism treatment outcome studies, 1970–1998

Swearingen, C. E., Moyer, A. E., & Finney, J. W. (2003) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00251-9 · Cited by 30 · see citing works

An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence

Sousa, A. D., & Sousa, A. D. (2008) · Journal of Substance Use · doi:10.1080/14659890802305861 · Cited by 29 · see citing works

THE ROLE OF ANXIETY IN PREDICTING DRINKING BEHAVIOUR

Sloan, T. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg090 · Cited by 29 · see citing works

Acamprosate: Safety and Tolerability in the Treatment of Alcohol Dependence

Rosenthal, R. N., Gage, A. T., Perhach, J. L., & Goodman, A. M. (2008) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31816319fd · Cited by 27 · see citing works

Alcohol Dependence and Its Treatment

Flannery, B., & Newlin, D. B. (2008)

Pharmacotherapy for alcohol dependence.

Wortman, S. P., Rabinowitz, A. R., & Oslin, D. W. (2005) · PubMed Central · Cited by 1 · see citing works

for Alcohol Dependence A Randomized Controlled Trial

Naltrexone, O. L.-A. I., Garbutt, J. C., Kranzler, H. R., O’malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., & Ehrich, E. W. (2014)

Non-Pharmacological Treatment of Alcohol Dependence

Jiloha, R. C. (2016)

The implications of genetic research on alcohol dependence for prevention and treatment

Mathews, R. R. S., Carter, A., & Hall, W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139058971.003 · Cited by 1 · see citing works